Weixue Si
Impact in
- Infectious Diseases top 10%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Viral gastroenteritis research and epidemiology
-
- Vaccine Coverage and Hesitancy
Papers in
- Oncology 2
- CAR-T cell therapy research 1
- Lung Cancer Research Studies 1
-
- SARS-CoV-2 and COVID-19 Research 1
- Co-authors
- Jianying Huang (1 shared paper)Yu Wang (1 shared paper)Xinghuan Wang (1 shared paper)Lihua Hou (1 shared paper)Jinlong Zhang (1 shared paper)Busen Wang (1 shared paper)Xiaohong Song (1 shared paper)Tao Zhu (1 shared paper)
- Journals
- European Journal of Medicinal Chemistry (1 paper)ACS Applied Materials & Interfaces (1 paper)The Lancet Infectious Diseases (1 paper)
- Partner nations
- China
In The Last Decade
Weixue Si
2 papers receiving 188 citations
Weixue Si's Hit Papers
Peers
Comparison fields: 5 of 49
- Infectious Diseases 136
- Health 36
- Animal Science and Zoology 25
- Immunology 35
- Pharmaceutical Science 9
Countries citing papers authored by Weixue Si
This map shows the geographic impact of Weixue Si's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weixue Si with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weixue Si more than expected).
Fields of papers citing papers by Weixue Si
This network shows the impact of papers produced by Weixue Si. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weixue Si. The network helps show where Weixue Si may publish in the future.
Co-authors
The 25 scholars most cited alongside Weixue Si, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Safety, tolerability, and immunogenicity of an aerosolised adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in adults: preliminary report of an open-label and randomised phase 1 clinical trial Hit paper breakdown → | 2021 | 192 |
| 2 | 2024 | 1 | |
| 3 | 2025 | 0 |
About Weixue Si
Weixue Si is a scholar working on Oncology, Infectious Diseases, Organic Chemistry, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 3 papers that have together received 193 indexed citations. Recurring topics across this work include CAR-T cell therapy research (1 paper), Influenza Virus Research Studies (1 paper), SARS-CoV-2 and COVID-19 Research (1 paper), Radiopharmaceutical Chemistry and Applications (1 paper), Glycosylation and Glycoproteins Research (1 paper), Inhalation and Respiratory Drug Delivery (1 paper), Lung Cancer Research Studies (1 paper) and Virus-based gene therapy research (1 paper). The work is most often cited by research in Infectious Diseases (136 citations), Health (36 citations), Animal Science and Zoology (25 citations), Immunology (35 citations) and Pharmaceutical Science (9 citations). Weixue Si has collaborated with scholars based in China. Frequent co-authors include Jianying Huang, Yu Wang, Xinghuan Wang, Lihua Hou, Jinlong Zhang, Busen Wang, Xiaohong Song, Tao Zhu, Chang Chen and Yi Chen. Their work appears in journals such as European Journal of Medicinal Chemistry, ACS Applied Materials & Interfaces and The Lancet Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.